潜伏 EBV 再激活驱动 EBV 阴性直肠癌肿瘤组织来源 TIL(肿瘤浸润淋巴细胞)体外扩增过程中的异常 B 细胞增殖 Latent EBV reactivation drives aberrant B-cell proliferation during ex vivo tumor-infiltrating lymphocyte expansion from EBV-negative rectal cancer tu PubMed 2025/11/24 发表Sci RepQ1 · IF 4.9(JCR 2025) 靶点:CD19靶点:CD20技术:CAR-T技术:TIL结直肠癌淋巴瘤